This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Potrykus, J.
Right arrow Articles by Wegrzyn, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Potrykus, J.
Right arrow Articles by Wegrzyn, G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2001, p. 3610-3612, Vol. 45, No. 12
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.12.3610-3612.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Chloramphenicol-Sensitive Escherichia coli Strain Expressing the Chloramphenicol Acetyltransferase (cat) Gene

Joanna Potrykus1 and Grzegorz Wegrzyn1,2,*

Department of Molecular Biology, University of Gdañsk, 80-822 Gdañsk,1 and Marine Biology Center, Polish Academy of Sciences, 81-347 Gdynia,2 Poland

Received 18 April 2001/Returned for modification 16 July 2001/Accepted 30 August 2001


    ABSTRACT
Top
Abstract
Text
References

An Escherichia coli strain (strain CM2555) bearing the chloramphenicol acetyltransferase (cat) gene was found to be sensitive to chloramphenicol. We demonstrate that the cat gene is efficiently expressed in strain CM2555. Our results suggest that decreased levels of acetyl coenzyme A in cat-expressing CM2555 cells in the presence of chloramphenicol may cause the bacterium to be sensitive to this antibiotic.


    TEXT
Top
Abstract
Text
References

One of the best-characterized bacterial antibiotic resistance mechanisms is the synthesis of chloramphenicol acetyltransferase (CAT) (3, 9, 12, 23). Production of this enzyme, encoded by the cat gene, is the most common means by which bacteria become resistant to chloramphenicol (13, 22), a small bacteriostatic antibiotic that interacts with a peptidyl transferase center (16). CAT catalyzes transfer of the acetyl moiety from acetyl coenzyme A (acetyl-CoA) to a chloramphenicol molecule (8, 12). Thus modified, chloramphenicol no longer binds to the ribosomes and protein synthesis proceeds (12).

Recently, an Escherichia coli strain, strain CM2555, was identified in which no transformants were selected when chloramphenicol was used as the selective agent during attempts to introduce plasmids carrying the cat gene (21). cat-bearing strain CM2555 was found to be sensitive to chloramphenicol (21). The aim of the work described here was to investigate the mechanism of this phenomemon.

The bacterial strains and plasmids used in this work are listed in Table 1.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   E. coli strains and plasmids used in the study

For Western blotting, after sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) with 12.5% polyacrylamide gels, or PAGE the proteins were transferred onto a nitrocellulose membrane (Bio-Rad) with a semidry blot apparatus (Schleicher & Schuell). The CAT protein was visualized with a specific anti-CAT serum (Sigma Aldrich) with alkaline phosphatase-conjugated secondary antibodies as described previously (20). The relative amount of CAT was estimated by densitometry.

Preparation of crude cellular extracts and spectrophotometric measurements of CAT biochemical activity were performed as described previously (11). The intracellular concentration of acetyl-CoA was determined spectrophotometrically as described earlier (10).

The efficiency of protein synthesis was estimated by measurement of the level of incorporation of radioactive precursors into trichloroacetic acid-precipitable material as described previously (18), but 14C-labeled amino acids (UVVVR) were added to bacterial cultures to a final concentration of 2.5 µCi/ml.

E. coli CM2555 has a genetic defect that leads to its chloramphenicol sensitivity in the presence of cat. Strain CM2555 has been described as one of the series of ilv+ dnaA mutants (CM2555 bears the dnaA508 allele) otherwise isogenic to strain CM732 (4). However, using a set of bacterial strains and plasmids (Table 1), we found that the chloramphenicol sensitivity of strain CM2555 bearing the cat gene is not caused by the dnaA508 allele or the combination of ilv+ and dnaA508 alleles (data not shown). Thus, we conclude that strain CM2555 must contain another, previously unidentified mutation(s) which makes it sensitive to chloramphenicol, despite the presence of the cat gene.

Expression of cat gene in strain CM2555. Densitometric analyses of electropherograms after SDS-PAGE and of Western blots with anti-CAT serum revealed that CM2555/pBR328 produces at least three times more CAT than the parental strain, CM732/pBR328 (data not shown). To test whether an increased level of CAT plays a role in the mechanisms of the chloramphenicol sensitivity of CM2555, we used plasmid pJKP1 bearing the cat gene under control of an inducible promoter, plac, together with another plasmid, pJMH1, harboring the lacIq allele. Addition of isopropyl-beta -D-thiogalactopyranoside (IPTG) to a final concentration of 1 mM resulted in CAT levels (in both CM2555 and CM732 hosts) that corresponded to about 90% of that found in CM732/pBR328 (data not shown). Contrary to the results obtained in control experiments, the increased efficiency of cat expression correlated with the faster growth of strain CM2555/pJKP1/pJMH1 in a chloramphenicol-containing medium only up to IPTG concentrations of 0.1 mM, and a further increase in the efficiency of cat expression resulted in the inhibition of bacterial growth (Fig. 1). Therefore, we suggest that the efficiency of expression of the cat gene may be important for the chloramphenicol sensitivity of strain CM2555.


View larger version (25K):
[in this window]
[in a new window]
  		FIG. 1.   Effect of intracellular amount of CAT on bacterial growth in the presence of chloramphenicol. E. coli CM732 and CM2555 harboring pJKP1 and pJMH1 were grown in Luria-Bertani liquid medium. cat gene expression from the plac-cat fusion was induced overnight, and then in the course of the experiment expression was maintained by the presence of various amounts of IPTG. Chloramphenicol was added when the optical density at 575 nm was 0.1. Doubling times were determined by monitoring bacterial growth (optical density at 575 nm) in the presence and absence of chloramphenicol (34 µg/ml). Symbols: open circles, CM732/pJKP1/pJMH1 grown without chloramphenicol; closed circles, CM732/pJKP1/pJMH1 grown in the presence of chloramphenicol; open rectangles, CM2555/pJKP1/pJMH1 grown without chloramphenicol; closed rectangles, CM2555/pJKP1/pJMH1 grown in the presence of chloramphenicol.

Activity of CAT protein in strain CM2555. We measured the acetylation of chloramphenicol and calculated that the total CAT activity per 1 mg of cellular proteins in strain CM2555/pBR328 was higher than that in analogous samples prepared from the parental strain, CM732/pBR328 (1.20 CAT activity units in CM2555/pBR328 versus 0.73 CAT activity units in CM732/pBR328). Moreover, CAT reveals biological activity in both CM2555/pBR328 and CM732/pBR328, as the addition of chloramphenicol (up to 34 µg/ml) to cultures of these strains had no significant effect on protein synthesis efficiency (data not shown).

Sensitivity to chloramphenicol of strain CM2555 expressing cat results from decreased levels of acetyl-CoA. Since CAT catalyzes the transfer of the acetyl group from acetyl-CoA to a chloramphenicol molecule, we measured the levels of acetyl-CoA in strain CM2555 and strain CM732 bearing plasmid pBR328 in the absence and presence of chloramphenicol. We found that the residual level of acetyl-CoA, without the addition of the antibiotic, was slightly lower in CM2555/pBR328 relative to that in CM732/pBR328 (the level of acetyl-CoA in CM2555/pBR328 was about 90% of that found in CM732/pBR328). However, after the addition of chloramphenicol, the level of acetyl-CoA was roughly constant in CM732/pBR328, while it gradually decreased in CM2555/pBR328 (Fig. 2A and B).


View larger version (21K):
[in this window]
[in a new window]
  		FIG. 2.   Intracellular amount of acetyl-CoA as affected by chloramphenicol in E. coli CM732/pBR328 (A) and CM2555/pBR328 (B) and the effect of sodium acetate on bacterial growth in the presence of chloramphenicol (C). In the experiments whose results are depicted in panels A and B, strains harboring pBR328 were grown in Luria-Bertani liquid medium. Chloramphenicol (34 µg/ml) was added when the optical density at 575 nm was 0.1 (time zero). Samples were withdrawn every 5 min after addition of the antibiotic and were then assayed for acetyl-CoA. For each strain, the amount of acetyl-CoA at time zero was taken to be 1, and the relative concentration was calculated. In the experiments whose results are depicted in panel C, E. coli CM732 and CM2555 harboring pBR328 were grown in Luria-Bertani liquid medium supplemented with different amounts of sodium acetate. Chloramphenicol was added when the optical density at 575 nm was 0.1. The doubling times of the cultures were determined by monitoring bacterial growth (optical density at 575 nm) in the presence and absence of chloramphenicol (34 µg/ml). The values presented are means from three experiments. In all cases the standard deviation was below 10%. Symbols: open circles, CM732/pBR328 grown without chloramphenicol; closed circles, CM732/pBR328 grown in the presence of chloramphenicol; open rectangles, CM2555/pBR328 grown without chloramphenicol; closed rectangles, CM2555/pBR328 grown in the presence of chloramphenicol.

To test whether a decrease in the level of acetyl-CoA in strain CM2555/pBR328 is responsible for the sensitivity of this strain to chloramphenicol, we measured the growth rates of bacterial cultures in the presence of sodium acetate. Sodium acetate can be used as an alternative source of acetyl-CoA production in cells (6). It was reported previously (12) that cat-expressing E. coli mutants with mutations in aceE or aceF, which cannot make acetyl-CoA from pyruvate but which can make acetyl-CoA from sodium acetate, are resistant to chloramphenicol only when sodium acetate is supplied. Thus, if the hypothesis stated above were true, we should have observed improved growth of CM2555/pBR328 in the presence of sodium acetate. Indeed, we found that the presence of sodium acetate dramatically improved the growth of CM2555/pBR328 in the medium containing chloramphenicol (Fig. 2C). We also found that strain CM2555 could be transformed by different plasmids bearing the cat gene when selection was performed on plates containing both chloramphenicol (34 µg/ml) and 0.15% sodium acetate (data not shown). Neither the pBR328 copy number nor the amount of CAT in CM2555 cells was affected by the presence of sodium acetate in the medium (data not shown). These results strongly support the hypothesis that decreased levels of acetyl-CoA in cat-expressing CM2555 cells in the presence of chloramphenicol result in the sensitivity of the bacterium to this antibiotic.


    ACKNOWLEDGMENTS

We are very grateful to S. Barañska and A. Szalewska-Palasz for assistance at the stage of preliminary experiments and to J. Davies for discussions and support at the beginning of this project.

This work was supported by the Polish State Committee for Scientific Research (project 6 P04A 060 18). G.W. also acknowledges financial support from the Foundation for Polish Science (subsidy 14/2000).


    FOOTNOTES

* Corresponding author. Mailing address: Department of Molecular Biology, University of Gdañsk, Kładki 24, 80-822 Gdañsk, Poland. Phone: 48 (58) 346 3014. Fax: 48 (58) 301 0072. E-mail: wegrzyn{at}biotech.univ.gda.pl.


    REFERENCES
Top
Abstract
Text
References

1. Bolivar, F., and K. Backman. 1979. Plasmids of Escherichia coli as cloning vectors. Methods Enzymol. 68:245-257[Medline].
2. Chang, C. Y., and S. N. Cohen. 1978. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the p15A cryptic miniplasmid. J. Bacteriol. 134:1141-1156[Abstract/Free Full Text].
3. Davies, J. 1994. Inactivation of antibiotics and the dissemination of resistance genes. Science 264:375-382[Abstract/Free Full Text].
4. Hansen, F. G., and K. von Meyenburg. 1979. Characterization of the dnaA, gyrB, and other genes in the dnaA region of the Escherichia coli chromosome on specialized transducing phages lambda-tna. Mol. Gen. Genet. 175:135-144[CrossRef][Medline].
5. Jensen, K. F. 1993. The Escherichia coli "wild types" W3110 and MG1655 have rph frame shift mutation that leads to pyrimidine starvation due to low pyrE expression levels. J. Bacteriol. 175:3401-3407[Abstract/Free Full Text].
6. Jones-Mortimer, M. C., and H. L. Kornberg. 1977. The enzymic interconversion of acetate and acetyl-coenzyme A in Escherichia coli. J. Gen. Microbiol. 102:327-336[Abstract/Free Full Text].
7. Kedzierska, S., M. Staniszewska, J. Potrykus, and G. Wegrzyn. 1999. The effects of some antibiotic-resistance-conferring plasmids on the removal of heat-aggregated proteins from Escherichia coli. FEMS Microbiol. Lett. 176:279-284[CrossRef][Medline].
8. Lewendon, A., and W. V. Shaw. 1993. Transition state stabilization by chloramphenicol acetyltransferase. J. Biol. Chem. 268:20997-21001[Abstract/Free Full Text].
9. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388[Abstract/Free Full Text].
10. Prübeta , B. M., and A. J. Wolfe. 1994. Regulation of acetyl phosphate synthesis and degradation, and the control of flagellar expression in Escherichia coli. Mol. Microbiol. 12:973-984[Medline].
11. Shaw, W. V. 1975. Chloramphenicol acetyltransferase from chloramphenicol-resistant bacteria. Methods Enzymol. 43:737-755[Medline].
12. Shaw, W. V. 1983. Chloramphenicol acetyltransferase: enzymology and molecular biology. Crit. Rev. Biochem. 14:1-46[Medline].
13. Shaw, W. V., L. C. Packman, B. D. Burleigh, A. Dell, H. R. Morris, and B. S. Hartley. 1979. Primary structure of a chloramphenicol acetyltransferase specified by R plasmids. Nature 282:870-872[CrossRef][Medline].
14. Silhavy, T. J., M. L. Berman, and L. W. Enquist. 1984. Experiments with gene fusions. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
15. Singer, M., T. A. Baker, G. Schnitzler, S. M. Deischel, M. Goel, W. Dove, K. J. Jaacks, A. D. Grossman, J. W. Erickson, and C. A. Gross. 1989. A collection of strains containing genetically linked alternating antibiotic resistance elements for genetic mapping of Escherichia coli. Microbiol. Rev. 53:1-24[Abstract/Free Full Text].
16. Vester, B., and R. A. Garret. 1988. The importance of highly conserved nucleotides in the binding region of chloramphenicol at the peptidyl transfer center of Escherichia coli 23S ribosomal RNA. EMBO J. 7:3577-3587[Medline].
17. Vieira, J., and J. Messing. 1988. The pUC plasmids, an M13mp7-derived system for insertional mutagenesis and sequencing with synthetic universal primers. Gene 19:259-268.
18. Wegrzyn, G., E. Kwasnik, and K. Taylor. 1991. Replication of lambda  plasmid in amino acid-starved strains of Escherichia coli. Acta Biochim. Pol. 38:181-186[Medline].
19. Wegrzyn, G., R. E. Glass, and M. S. Thomas. 1992. Involvement of the Escherichia coli RNA polymerase alpha  subunit in transcriptional activation by the bacteriophage lambda  CI and CII proteins. Gene 122:1-7[CrossRef][Medline].
20. Wegrzyn, A., G. Wegrzyn, and K. Taylor. 1995. Protection of coliphage lambda O initiator protein from proteolysis in the assembly of the replication complex in vivo. Virology 207:179-184[CrossRef][Medline].
21. Wegrzyn, G., A. Wegrzyn, A. Pankiewicz, and K. Taylor. 1996. Allele specificity of the Escherichia coli dnaA gene function in the replication of plasmids derived from phage lambda . Mol. Gen. Genet. 252:580-586[Medline].
22. Zaidenzaig, Y., J. E. Fitton, L. C. Packman, and W. V. Shaw. 1979. Characterization and comparison of chloramphenicol acetyltransferase variants. Eur. J. Biochem. 100:609-618[Medline].
23. Zgurskaya, H. I., and H. Nikaido. 2000. Multidrug resistance mechanisms: drug efflux across two membranes. Mol. Microbiol. 37:219-225[CrossRef][Medline].

Antimicrobial Agents and Chemotherapy, December 2001, p. 3610-3612, Vol. 45, No. 12
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.12.3610-3612.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Potrykus, J.
Right arrow Articles by Wegrzyn, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Potrykus, J.
Right arrow Articles by Wegrzyn, G.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»